Immunoglobulin Y antibodies against colonization-related genes block the growth and infection of Helicobacter pylori

QR Code

Immunoglobulin Y antibodies against colonization-related genes block the growth and infection of Helicobacter pylori

IntroductionImmunoglobulin Y (IgY) has emerged as a promising antibody therapy for the eradication of Helicobacter pylori (H. pylori) independent of antibiotics. However, the roles and differences of IgY antibodies targeting various genes against H. pylori remain unclear.MethodsThe recombinant antig...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shiyuan Deng, Xiaoling Luo, Yunxiao Du, Rania G. Elbaiomy, Weihan He, Rong Guo, Ahmed H. El-Sappah, Xiaohong Jian, Yongmei Xie, Mohammed Bakeer, Zaixin Li, Zhi Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Immunology
Subjects:	immunoglobulin Y Helicobacter pylori growth infection eradication rate
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1582250/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New Approaches to Therapy of Helicobacter pylori Infection (by the Materials of the Maastricht Consensus-IV, Florence, 2010)
by: A. G. Evdokimova, et al.
Published: (2020-05-01)

Benefits of Helicobacter pylori Eradication on Extragastric Diseases
by: Tae Jun Kim, et al.
Published: (2021-12-01)

Eradication of Helicobacter pylori: a prospective comparative randomized trial of standard versus optimized quadruple therapy
by: Salma Souissi, et al.
Published: (2024-12-01)

Infection <i>Helicobacter pylori</i> and stomach cancer: state-of-the-art
by: A. A. Sheptulin
Published: (2012-04-01)

Discussion of <i>Helicobacter pylori</i> infection issue in reports of the 19-th United European Gastroenterology Week
by: A. A. Sheptulin, et al.
Published: (2012-09-01)

Regional features of gastroduodenal disease, associated with Helicobacter pylori infection, in the North Ossetia
by: E. A. Kornienko, et al.
Published: (2014-09-01)

Compliance with Helicobacter pylori eradication: modern approaches to increase in commitment and the results of own research
by: T. A. Ilchishina
Published: (2021-06-01)

DIAGNOSTICS OF HELICOBACTER PYLORI INFECTION BY ENZYME IMMUNOASSAY IN PATIENTS WITH CALCULOUS CHOLECYSTITIS
by: A. A. Yashnov, et al.
Published: (2017-11-01)

The Clinical Features and Helicobacter pylori Eradication Therapy in Lymphofollicular Gastritis: A Single Center Experience
by: Hong Ju An, et al.
Published: (2016-12-01)

THE PROBLEM OF ANTIBIOTIC RESISTANCE OF HELICOBACTER PYLORI ON THE MODERN STAGE AND ITS CLINICAL SIGNIFICANCE FOR PRACTICAL MEDICINE
by: A. V. Nalyotov
Published: (2015-03-01)

Beyond antibiotics: probiotics as a promising ally against Helicobacter pylori
by: Lin Yuan, et al.
Published: (2025-07-01)

Efficacy and safety of bismuth quadruple regimens containing minocycline and vonoprazan for eradication of Helicobacter pylori: Real‐world evidence
by: Qiyunna He, et al.
Published: (2024-05-01)

Impact of combined fixed-dose formulations in Helicobacter pylori eradication on incidence rate of gastric cancer in Ukraine from 2014 to 2021
by: Y.O. Protas, et al.
Published: (2025-03-01)

Efficiency of ursodeoxycholic acid in the frameworks of minimization of hepatotoxic potential of eradication therapy of Helicobacter pylori infection
by: D. N. Andreev, et al.
Published: (2021-06-01)

ASSESSMENT OF RELATED ANAMNESTIC AND CLINICAL FACTORS ON EFFICACY AND SAFETY OF ANTI-HELICOBACTER PYLORI THERAPY
by: D. N. Andreev, et al.
Published: (2016-03-01)

Improving the effectiveness of eradication therapy for Helicobacter pylori infection
by: E. A. Ljaljukova, et al.
Published: (2024-12-01)

Trends in the prevalence of <i>Helicobacter pylori</i> infection among adults in Moscow: a systematic review and meta-analysis
by: Dmitry N. Andreev, et al.
Published: (2025-01-01)

Seroprevalence of anti-<i>Helicobacter pylori</i> antibodies in population of Azerbaijan, Iran
by: H. E. Leylabadlo, et al.
Published: (2023-11-01)

DIAGNOSIS AND TREATMENT OF HELICOBACTER PYLORI INFECTION: MAIN STATEMENTS OF THE MAASTRICHT V/FLORENCE CONSENSUS REPORT (2015)
by: I. V. Maev, et al.
Published: (2017-04-01)

First-line Helicobacter pylori Eradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective Study
by: Moon Won Lee, et al.
Published: (2018-06-01)

Role of adjuvant therapy in the treatment of helicobacter pylori infection in children.
by: O. N. Gerasymenko
Published: (2014-06-01)

Helicobacter pylori in children: modern aspects of diagnosis and treatment in the light of the latest international recommendations
by: І.М. Несіна, et al.
Published: (2024-12-01)

Review of the European <i>Helicobacter</i> Study Group Workshop reports (Ljubljana, 2012)
by: A. A. Sheptulin
Published: (2013-07-01)

Standard First-line Triple Therapy for Helicobacter pylori Infection: A Comparison of Eradication Rates Based on Timing of Administration of Proton Pump Inhibitors
by: Seong Ju Lee, et al.
Published: (2018-06-01)

Adherence of primary care providers to implementing recommendations for the diagnosis and treatment of Helicobacter pylori-associated dyspepsia: survey results
by: I.H. Palii, et al.
Published: (2025-06-01)

The results of the effectiveness of pharmaceutical treatment of chronic gastritis with erosions associated with <i>Helicobacter pylori</i>with azithromycin and amoxicillin in the elderly
by: T. E. Afanasenkova, et al.
Published: (2024-04-01)

Treatment of chronic inflammatory diseases among children – DRAMa helicobacteriosis
by: P. L. Tsherbakov, et al.
Published: (2005-12-01)

Cytoprotection of the Gastric Mucosa and Eradication Therapy of <i>Helicobacter Pylori</i> Infection: Points of Conjugation
by: A. S. Trukhmanov, et al.
Published: (2025-06-01)

STRUCTURAL AND FUNCTIONAL FEATUREs OF THE LIVER WITH MARKERS OF HCV- AND HBV-INFECTION AND OF gastric mucosa FOR Varying degrees of <i>Helicobacter pylori </i>COLONIZATION
by: D. L. Nepomnyashchikh, et al.
Published: (2019-02-01)

Possible role of Lactobacillus reuteri for eradication of Helicobacter pylori in adults in real clinical practice
by: I. B. Khlynov, et al.
Published: (2021-06-01)

Clinical and Pharmacological Aspects of Resistance to Eradication Therapy of Helicobacter Pylori Infection
by: S. Yu. Serebrova, et al.
Published: (2020-05-01)

Biological Cost of Helicobacter pylori Rifampicin Resistance
by: K. T. Momynaliev, et al.
Published: (2020-05-01)

Efficacy and safety of nitazoxanide based quadruple regimen as first line therapy for treating Helicobacter pylori infected naïve patients
by: Amro M Hassan, et al.
Published: (2025-06-01)

Eradication Therapy for Pediatric Helicobacter pylori Infection
by: Ji-Hyun Seo, et al.
Published: (2017-03-01)

Helicobacter pylori-negative Peptic Ulcer
by: Ji Hyun Song, et al.
Published: (2017-09-01)

Management of Helicobacter pylori Infection in Europe: Focusing on the Maastricht V/Florence Consensus
by: Woon Geon Shin
Published: (2017-03-01)

Serum Assay Findings after Successful Helicobacter pylori Eradication
by: Sun-Young Lee
Published: (2021-12-01)

Recent Changes in the Treatment of Helicobacter pylori Infection in Children and Adolescents
by: Ji-Hyun Seo, et al.
Published: (2021-09-01)

Chemoprevention of Gastric Cancer: Helicobacter pylori Eradication
by: Eun Jin Kim, et al.
Published: (2017-12-01)

Bismuth-containing drugs in clinical practice in the XXI century - history or a new round of possibilities?
by: V. A. Akhmedov
Published: (2024-09-01)